Form D — Andson Biotech Inc.
0002017131-25-000004 · filed Oct 22, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $5,000,000
- Reported amount sold
- $4,735,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Andson Biotech Inc.
- CIK
- 2017131
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 1705 COMMERCE DR NW
ATLANTA, Georgia 30318 - Phone
- 7273897725
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Mason Chilmonczyk · Executive OfficerAtlanta, Georgia Find on LinkedIn ↗
-
Andrei Fedorov · DirectorAtlanta, Georgia Find on LinkedIn ↗
-
Thomas O'Brien · DirectorAtlanta, Georgia Find on LinkedIn ↗
-
James Ross · DirectorAtlanta, Georgia Find on LinkedIn ↗
-
Jim Filippini · Executive OfficerAtlanta, Georgia Find on LinkedIn ↗
-
Glenn Epstein · DirectorAtlanta, Georgia Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗